May 29, 2013 | Letter

Except: Prescription drug counterfeiters have placed our nation's patients at risk; their criminal actions take advantage of the current patchwork of state laws that could allow venue‐shopping for the best locale in which to expose patients to unsafe and counterfeit prescription drugs.

>>
May 15, 2013 | Letter

To read EPA's May 15, 2013, response, click here.

>>
April 17, 2013 | Letter

To read a letter signed by the rare disease patient community organizations, click here

>>
April 16, 2013 | Letter

To read the March 5, 2013 letter to FDA, click here.

To read FDA's April 16, 2013, response, click here.

>>

Pages